COYA stock news · Coya Therapeutics, Inc.
Get alerts for COYA
Follow Coya Therapeutics, Inc. (COYA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for COYAFree on the App Store and Google Play, or on the web.
Coya Therapeutics shared its financial results for the quarter that ended on September 30, 2026.
NeutralCOYA filed a report saying it issued a press release about the quarter ended September 30, 2026, but this text gives no figures. It does not show a change in the company's outlook.
Coya Therapeutics, Inc. is starting a new phase of its ALSTARS Trial for COYA 302.
NeutralCoya plans to extend access to COYA 302 in its ALS study but pushed its FTD study to 2027. With no new trial results, the report leaves its outlook unchanged.